Quantcast

Latest Parkinson's disease Stories

2014-10-24 08:26:10

BOSTON, Oct. 24, 2014 /PRNewswire/ -- Rhythm announced today the presentation of results from a Phase 2a clinical trial assessing the safety and efficacy of relamorelin (RM-131) in 48 patients with chronic constipation. Analysis of the data indicates that relamorelin administered once daily for two weeks in patients with chronic constipation significantly improves constipation symptoms, along with accelerating colonic transit. The study results were presented in a late-breaker session at the...

2014-10-23 23:03:53

Alice Lazzarini, PhD, and internationally recognized researcher in neurogenetic disorders, announces the donation of a portion of proceeds from Both Sides Now: A Journey From Researcher to Patient to the American Parkinson Disease Association(APDA) New York, NY (PRWEB) October 23, 2014 Dr. Lazzarini's support through the sales of her book will raise funds to help Ease the Burden – Find the Cure for the 1 million individuals in the United States living with Parkinson disease. Both...

2014-10-23 08:34:33

REHOVOT, Israel, October 23, 2014 /PRNewswire/ -- NeuroDerm Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced that top-line results for ND0612L from a phase II study in patients with moderate Parkinson's patients, and preliminary interim results from a phase IIA study of ND0612H and ND0612L in advanced Parkinson's patients, will be presented at The Michael J. Fox Foundation's 2014 Parkinson's Disease...

2014-10-21 16:26:03

ATLANTA, Oct. 21, 2014 /PRNewswire-USNewswire/ -- In honor of Lewy Body Dementia (LBD) Awareness Month, the Lewy Body Dementia Association proudly unveils, "The Profiles of LBD," a portrait series of families living with the disease. Taken by world-renowned professional photographer, Robert Whitman, the series encapsulates the love between those afflicted with LBD and their caregivers, despite the struggles they face together every day managing a relatively unknown, yet very common,...

2014-10-20 12:29:44

The Parkinson Alliance Reports Findings Pertaining to Autonomic Dysfunction in Parkinson's KINGSTON, N.J., Oct. 20, 2014 /PRNewswire-USNewswire/ -- New findings from The Parkinson Alliance (PA) survey entitled "Autonomic Dysfunction in Parkinson's Disease With and Without Deep Brain Stimulation" show that autonomic dysfunction was highly prevalent in Parkinson's disease (PD), regardless of age and disease duration. The autonomic nervous system controls a number of functions in the...

2014-10-15 16:29:22

COLUMBUS, Ohio, Oct. 15, 2014 /PRNewswire/ -- OhioHealth "Delay the Disease", an evidenced-based fitness program designed for people with Parkinson's Disease, is one of the newest members of the OhioHealth family of neuroscience programs. The community-based wellness program is designed to empower those living with Parkinson's Disease by optimizing their physical function and helping to delay the progression of symptoms associated with Parkinson's Disease. To view the multimedia...

2014-10-14 23:04:28

In its thirty-six year history, the American Parkinson Disease Association Cozias Fellowship has been awarded to only twenty-eight scientific investigators New York, NY (PRWEB) October 14, 2014 The American Parkinson Disease Association is pleased to announce the application process for this prestigious award is now open. The George C. Cotzias, MD Memorial Fellowship was developed by the American Parkinson Disease Association (APDA) in 1979 to honor Dr. Cotzias who was a pathfinder in...

2014-10-14 12:26:46

Sales of a Novel Antipsychotic and an Improved Rescue Therapy Will Contribute Approximately $1 Billion to the PD Market in 2023, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct. 14, 2014 /PRNewswire/ -- Decision Resources Group finds that the Parkinson's disease (PD) pharmacotherapy market will grow 5 percent annually from $2.3 billion in 2013 to $3.8 billion in 2023. This growth will be fueled by the launch of several emerging therapies--including new molecular...

2014-10-14 08:34:19

Allied Team Training for Parkinson's Disease will be held in San Diego, CA this November MIAMI, Oct. 14, 2014 /PRNewswire-USNewswire/ -- The National Parkinson Foundation (NPF) and the International Parkinson and Movement Disorder Society (MDS) Pan American Section (MDS-PAS) announced today a collaborative partnership to offer a three-day course to teach team care and increase knowledge of Parkinson's disease (PD). The course, Allied Team Training for Parkinson's Disease (ATTP) will...

2014-10-14 08:33:10

Robust Clinical Development Programs Across Sellas' Portfolio of Drugs and Biologics ZUG, Switzerland and NEW YORK, Oct. 14, 2014 /PRNewswire/ -- SELLAS Life Sciences Group (SELLAS), a Swiss-based development-stage biopharmaceutical company, today announced that it has signed a definitive master service agreement with Pharmaceutical Product Development (PPD), a leading global contract research organization (CRO), to advance and expand clinical and regulatory development across...


Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin